<code id='77713D1BA3'></code><style id='77713D1BA3'></style>
    • <acronym id='77713D1BA3'></acronym>
      <center id='77713D1BA3'><center id='77713D1BA3'><tfoot id='77713D1BA3'></tfoot></center><abbr id='77713D1BA3'><dir id='77713D1BA3'><tfoot id='77713D1BA3'></tfoot><noframes id='77713D1BA3'>

    • <optgroup id='77713D1BA3'><strike id='77713D1BA3'><sup id='77713D1BA3'></sup></strike><code id='77713D1BA3'></code></optgroup>
        1. <b id='77713D1BA3'><label id='77713D1BA3'><select id='77713D1BA3'><dt id='77713D1BA3'><span id='77713D1BA3'></span></dt></select></label></b><u id='77713D1BA3'></u>
          <i id='77713D1BA3'><strike id='77713D1BA3'><tt id='77713D1BA3'><pre id='77713D1BA3'></pre></tt></strike></i>

          knowledge

          knowledge

          author:focus    Page View:23357
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study
          Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

          AdobeAcadiaPharmaceuticalssaidMondaythatitsapprovedmedicinecalledNuplazidfailedtoimprovethesocialand

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          RaDonda Vaught links Vanderbilt hospital issues to patient death

          RaDondaVaughtsitsinacourtroomaheadofhersentencinginNashville,Tenn.,onFriday,May13,2022.NicoleHester/